HYPERZOL Trademark

Trademark Overview

On Tuesday, November 28, 2017, a trademark application was filed for HYPERZOL with the United States Patent and Trademark Office. The USPTO has given the HYPERZOL trademark a serial number of 87699493. The federal status of this trademark filing is REGISTERED as of Tuesday, April 13, 2021. This trademark is owned by NuRemedy Pharma LLC. The HYPERZOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations or formulations for transdermal delivery of treatments
hyperzol

General Information

Serial Number87699493
Word MarkHYPERZOL
Filing DateTuesday, November 28, 2017
Status700 - REGISTERED
Status DateTuesday, April 13, 2021
Registration Number6322522
Registration DateTuesday, April 13, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements

Pseudo MarkHYPER ZOL
Goods and ServicesPharmaceutical preparations or formulations for transdermal delivery of treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 7, 2017
Primary Code005
First Use Anywhere DateTuesday, August 18, 2020
First Use In Commerce DateTuesday, August 18, 2020

Trademark Owner History

Party NameNexzol Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
US
Party NameNexzol Pharma, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
US
Party NameNuRemedy Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144
US
Party NameNuRemedy Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144
US

Trademark Events

Event DateEvent Description
Friday, December 1, 2017NEW APPLICATION ENTERED
Thursday, December 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 12, 2018ASSIGNED TO EXAMINER
Monday, March 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, March 12, 2018EXAMINERS AMENDMENT E-MAILED
Monday, March 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 12, 2018EXAMINER'S AMENDMENT ENTERED
Monday, March 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 18, 2018ASSIGNED TO LIE
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 17, 2018SOU TEAS EXTENSION RECEIVED
Monday, December 17, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 17, 2018SOU EXTENSION 1 FILED
Wednesday, January 2, 2019SOU EXTENSION 1 GRANTED
Thursday, January 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 22, 2019ABANDONMENT - NO USE STATEMENT FILED
Monday, July 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, July 24, 2019TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 24, 2019PETITION TO REVIVE-GRANTED
Wednesday, July 24, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 25, 2019NOTICE OF REVIVAL - E-MAILED
Wednesday, June 19, 2019SOU EXTENSION 2 FILED
Tuesday, August 27, 2019SOU EXTENSION 2 GRANTED
Wednesday, August 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2019SOU TEAS EXTENSION RECEIVED
Thursday, December 12, 2019SOU EXTENSION 3 FILED
Thursday, December 12, 2019SOU EXTENSION 3 GRANTED
Saturday, December 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, July 20, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, August 18, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, August 18, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 18, 2020PETITION TO REVIVE-GRANTED
Tuesday, August 18, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 19, 2020NOTICE OF REVIVAL - E-MAILED
Friday, June 19, 2020SOU EXTENSION 4 FILED
Wednesday, September 23, 2020SOU EXTENSION 4 GRANTED
Tuesday, August 18, 2020USE AMENDMENT FILED
Wednesday, September 23, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 23, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 23, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 5, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 6, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 13, 2021REGISTERED-PRINCIPAL REGISTER
Monday, April 13, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

hyperzol delivery treatments transdermal formulations preparations pharmaceutical